[PDF][PDF] Minimal residual disease monitoring in chronic myeloid leukemia patients after allogeneic hematopoietic stem cell transplantation using interphase …

HQ Zhu, XL Liu, LL Song, QF Liu, FY Meng… - Chin J …, 2010 - scholar.archive.org
… of the tumor load in chronic myeloid leukemia [J]. Ai Zheng, … minimal residual disease in
chronic myeloid leukemia [J]. … with chronic myelogenous leukemia in chronic phase treated …

Clinical significance of detection of Ph chromosome and Bcr-abl mRNA in chronic myeloid leukemia/慢性粒细胞白血病Ph 染色体和bcr-abl mRNA 定量检测的临床意义

L Xiao-dong, FAN Rui-hua, HU Jie-ying… - Xi'an jiao tong da …, 2010 - search.proquest.com
… Objective: To evaluate the significance of Ph chromosome and bcr-abl mRNA expressions
in diagnosis, staging and treatment of chronic myeloid leukemia (CML) as well as in …

[HTML][HTML] … Off on The US FDA has issued full approval for Israeli drugmaker Teva's Synribo (omacetaxine mepesuccinate) 高三尖杉酯碱for chronic myeloid leukaemia  …

OFT BLOG - allfordrugs.com
… for the treatment of … treatment of Chronic Myelogenous Leukemia. It was approved by the
USFDA on 26th October 2012 for the treatment of adult patients with chronic myeloid leukemia (…

194 例CML 患者染色体核型及ABL 激酶区突变检测的临床

孙云霞 - 2017 - ir.lzu.edu.cn
… "China Guidelines for the Diagnosis and Treatment of Chronic Myeloid Leukemia", for
warning and treatment failure in patients with BCR-ABL kinase mutation detection. In this study, …

慢性粒细胞白血病BCR-ABL 融合基因实时定量检测平台的建立

黄丹, 高贝贝, 李莉, 苏晶莹, 高源, 闫金松… - 大连医科大学 …, 2014 - journal.dmu.edu.cn
diagnosis and treatment of chronic myeloid leukemia (CML), we aim to establish a diagnosis
… With pMD 18T BCR-ABL plasmid as reference standard and ABL as an internal control, we …

[HTML][HTML] 苯所致慢性髓性白血病5 例临床分析

詹昱, 杨志前, 曲佳, 冯可欣, 杨郁青, 谭明珠… - 职业卫生与应急 …, 2021 - oher.com.cn
… Clinical analysis of 5 cases with chronic myelogenous leukemiachronic myelogenous
leukemia(CML)caused by benzene, so as to strengthen prevention and standard treatment

[PDF][PDF] 以慢性粒细胞白血病为表现的原发性骨髓纤维化1 例报告附文献复习

郑梦力, 许智平, 郑智康, 陈丹, 黄健 - 实用检验医师杂志, 2021 - cccm-em120.com
… myelofibrosis manifested by chronic myelogenous leukemia and literature … diagnosis and
treatment of a patient with primary myelofibrosis (PMF) manifested by chronic myeloid leukemia

以血小板异常增高为表现的慢性粒细胞白血病合并脑出血患者成功救治一例

张鑫, 张笑, 郭毅, 冯俊, 肖志源, 解兆祥, 武静… - 协和医学 …, 2024 - xhyxzz.pumch.cn
… [摘要] 血小板升高为慢性粒细胞白血病(chronic myeloid leukemia, CML) 患者外周血的罕见
表现. 本文首次报 道1例以血小板异常增高为表现的CML合并脑出血病例. 该患者外周血血小板升高…

[PDF][PDF] 非小细胞肺癌程序性死亡配体1 与EGFR 基因突变相关性研究

鄢丽敏, 李雪梅, 雷冲, 闫继东, 张志勇 - 河北医学 - hbyxzzs.cn
… 2ꎻ q12) in chronic myeloid leukemia: a case report [ J]. … “Breakpoint mapping of at (9ꎻ22ꎻ
12) chronic myeloid leukaemia … in a philadelphia - positive chronic myeloid leukemia case[J].…

基于诊疗规范的慢性髓细胞白血病治疗单元费用研究

王淑慧, 苏丽华, 杨凡 - 中国医院管理, 2017 - zgyygl.com
… Based on the disease diagnosis and treatment standard of chronic myeloid leukemia, which
is listed in the book named " Specification for Diagnosis and Treatment of Blood Diseases”, …